What I Do and Why: HBV Treatment Strategies for Diverse Patient Populations

Featuring interactive multimedia modules, downloadable slidesets, and expert-authored ClinicalThought commentaries from US and European faculty, this program explores in depth why leading experts make specific HBV management decisions in their own practices and equips learners with key strategies for treating a diverse array of patients.
Mindie H. Nguyen, MD, MAS, AGAF, FAASLD
Program Director
person default
Joseph Ahn, MD, MS, MBA
Anna Christina L. dela Cruz, MD

HBV Complex Cases

In this interactive virtual module, expert faculty discuss how they would manage complex patients with HBV infection based on individual patient factors and current guidelines; topics include fibrosis assessment, pregnancy, and using qHBsAg to assess inactive carrier status.

Mindie H. Nguyen, MD, MAS, AGAF, FAASLD
Program Director
person default Joseph Ahn, MD, MS, MBA Anna Christina L. dela Cruz, MD
Physicians: maximum of 1.0 AMA PRA Category 1 Credit Released: July 20, 2020 Expired: July 19, 2021

Review guideline recommendations informing HBV management strategies for complex cases and learn how expert faculty would approach each case; topics include fibrosis assessment, pregnancy, and using qHBsAg to assess inactive carrier status.

person default Joseph Ahn, MD, MS, MBA Anna Christina L. dela Cruz, MD Released: July 21, 2020

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue